Catalyst Wire Dossier Catalyst Wire Dossier

DRM02

· Dermira, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DRM02, covering 2021-07-20 to 2021-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis [Phase 2]

See pricing